NCT07256119 Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
| NCT ID | NCT07256119 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-08-06 |
| Primary Completion | 2025-12-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-08-06 with a primary completion date of 2025-12-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
the purpose of this study is to evaluate the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
Eligibility Criteria
Inclusion Criteria: * Women aged ≥18 years. * Histologically confirmed invasive, early-stage breast carcinoma scheduled for adjuvant radiotherapy. * Receiving total radiation dose of 40 Gy for 15 sessions. Exclusion Criteria: * Prior exposure to radiotherapy. * Inflammatory or metastatic breast carcinoma. * Patients with connective tissue disorders. * Patients with skin inflammatory diseases (e.g. ectopic dermatitis). * Patients with known allergy or hypersensitivity to alpha lipoic acid. * Concomitant use of nonsteroidal anti-inflammatory drugs, corticosteroids, or antioxidant medications. * Patients who will fail to sign the written consent.
Contact & Investigator
Rana Mohamed Elsayed Kelany Abdelkader
PRINCIPAL INVESTIGATOR
Faculty of Pharmacy, Ain Shams University
Frequently Asked Questions
Who can join the NCT07256119 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 75 Years, studying Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07256119 currently recruiting?
Yes, NCT07256119 is actively recruiting participants. Contact the research team at rana.mohamed18@pharma.asu.edu.eg for enrollment information.
Where is the NCT07256119 trial being conducted?
This trial is being conducted at Zagazig, Egypt.
Who is sponsoring the NCT07256119 clinical trial?
NCT07256119 is sponsored by Ain Shams University. The principal investigator is Rana Mohamed Elsayed Kelany Abdelkader at Faculty of Pharmacy, Ain Shams University. The trial plans to enroll 40 participants.